Does EVEROLIMUS Cause Metastases to bone marrow? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Metastases to bone marrow have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.0% of all adverse event reports for EVEROLIMUS.
9
Reports of Metastases to bone marrow with EVEROLIMUS
0.0%
of all EVEROLIMUS reports
7
Deaths
3
Hospitalizations
How Dangerous Is Metastases to bone marrow From EVEROLIMUS?
Of the 9 reports, 7 (77.8%) resulted in death, 3 (33.3%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Metastases to bone marrow Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Metastases to bone marrow?
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (40)
CYTARABINE (36)
CARBOPLATIN (35)
ZOLEDRONIC ACID (32)
ETOPOSIDE (31)
OXALIPLATIN (30)
RIBOCICLIB (29)
RITUXIMAB (29)
VINCRISTINE (28)
Which EVEROLIMUS Alternatives Have Lower Metastases to bone marrow Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE